Share Prices & Company Research

Stockbroking

Vectura Group

Current Price 85.70p Bid 84.95p Ask 85.00p Change 0.65%
Last Updated: 27/05/2018 14:35. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Vectura Group plc is an industry-leading device and formulation business for inhaled airways products offering a uniquely integrated inhaled drug delivery platform. With its extensive range of device and formulation technologies, integrated capabilities and collaborations, it is a leader in the development of inhalation products, increasing its ability to help patients suffering from respiratory diseases. Vectura has eight inhaled, four non-inhaled and ten oral products marketed by partners with growing global royalty streams. The Group has a diverse portfolio of drugs in clinical development, including a number of novel and generic programmes which are partnered with several global pharmaceutical and biotechnology companies including Hikma, Novartis, Sandoz, Mundipharma, Kyorin, Baxter, GSK, UCB, Ablynx, Grifols, Bayer, Chiesi, Almirall, Janssen, Dynavax and Tianjin KingYork along with two wholly owned nebulised development.

Financial Highlights Year Ended 31/12/2017

Turnover
£148.00m
Operating Profit
£-96.20m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
-6.75

Key Personnel

James Ward-Lilley
Chief Executive Officer
Mehul Andrew Derodra
Chief Financial Officer
Bruno Francois Jules Angelici
Non-Executive Chairman
Frank Charles Condella
Non-Executive Dep Chairman
Juliet Thompson
Non-Executive Director
Ann Whitaker
Non-Executive Director
Dr Thomas Werner
Non-Executive Director
Dr Per-Olof Andersson
Non-Executive Director
Dr Susan Elizabeth Foden
Non-Executive Director
Neil William Warner
Non-Executive Director

Stock Details

EPIC
VEC
ISIN
GB00B01D1K48
Shares in Issue
664,393,787
Market cap
£565.40m

Analyst Views (7)

Strong Buy
 
71.43%
Buy
 
0.00%
Hold
 
28.57%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
85.00p
Bid Price
84.95p
Ask Price
85.00p
Volume
2383273
Change Today
0.55p
% Change Today
0.65%
Open
84.80p
Previous Close
85.00p
Intraday High
86.55p
Intraday Low
84.30p
52 Week High
127.20p
52 Week Low
68.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Vectura Group Intra-day Chart

Vectura Group News

News in this section is provided by MoneyAM

Vectura revenues in line with expectations 17 May 2018 | 09:03 Director Deals - Vectura Group PLC (VEC) 10 May 2018 | 12:55 High US treasury yields put global equities under pressure 24 Apr 2018 | 16:52 Uncertainty over May interest rate hike supports FTSE 20 Apr 2018 | 16:51 Broker Forecast - Shore Capital issues a broker note on Vectura Group PLC 20 Apr 2018 | 13:50 FTSE rises amid shifting rate expectations 20 Apr 2018 | 11:54 Broker Forecast - Peel Hunt issues a broker note on Vectura Group PLC 19 Apr 2018 | 12:40 Director Deals - Vectura Group PLC (VEC) 12 Apr 2018 | 14:10 Director Deals - Vectura Group PLC (VEC) 26 Mar 2018 | 11:40 Director Deals - Vectura Group PLC (VEC) 23 Mar 2018 | 12:25 Broker Forecast - Peel Hunt issues a broker note on Vectura Group PLC 23 Mar 2018 | 09:50 Director Deals - Vectura Group PLC (VEC) 22 Mar 2018 | 16:35 Broker Forecast - Stifel issues a broker note on Vectura Group PLC 22 Mar 2018 | 13:20 Broker Forecast - Numis issues a broker note on Vectura Group PLC 22 Mar 2018 | 12:30 Director Deals - Vectura Group PLC (VEC) 22 Mar 2018 | 11:40 Vectura Group losses more than double on asset write-downs 21 Mar 2018 | 07:30 Broker Forecast - Citigroup issues a broker note on Vectura Group PLC 20 Mar 2018 | 08:50 FTSE hit by surge in pound on Brexit transition deal reports 12 Mar 2018 | 16:52 Hikma Pharmaceutical loses dispute with FDA over asthma treatment 12 Mar 2018 | 13:49 FTSE flat on weaker miners 12 Mar 2018 | 11:55 Director Deals - Vectura Group PLC (VEC) 15 Feb 2018 | 11:45 Broker Forecast - Peel Hunt issues a broker note on Vectura Group PLC 14 Feb 2018 | 09:10 Director Deals - Vectura Group PLC (VEC) 18 Jan 2018 | 11:45 Broker Forecast - JP Morgan Cazenove issues a broker note on Vectura Group PLC 05 Jan 2018 | 11:20 Vectura revenues in line 04 Jan 2018 | 08:15 Market report: FTSE in positive end of year mood 29 Dec 2017 | 09:05 FTSE grinds to a halt amid lack of large cap news 28 Dec 2017 | 16:39 Broker Forecast - RBC Capital Markets issues a broker note on Vectura Group PLC 14 Dec 2017 | 12:00 Director Deals - Vectura Group PLC (VEC) 12 Dec 2017 | 15:55 Vectura Group appoints new director 29 Nov 2017 | 07:44

Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Tangible Assets
53.1
54.8
Intangible Assets & Goodwill
496.8
619.6
Investments & Other Non-Current Assets
7.4
4.0
Total Non-Current Assets
557.3
678.4
Inventory
23.4
18.4
Trade & Receivables
34.1
56.6
Cash & Receivables
103.7
92.5
Other Current Assets & Assets Held for Resale
0.0
0.0
Total Assets
718.5
845.9

Liabilities (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Short Term Liabilities
70.1
70.3
Long Term Liabilities
69.9
98.4
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
140.0
168.7

Net Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Net Assets
578.5
677.2

Equity (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Share Capital
0.2
0.2
Minority Interests
0.0
0.0
Retained Earnings
-108.6
-23.7
Share Premium Account
102.8
102.3
Other Equity
584.1
598.4
Total Equity
578.5
677.2

Cashflow (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Cashflow from Operating Activities
26.1
28.2
Cashflow Before Financing
16.6
18.3
Increase / Decrease in Cash
11.2
-7.3

Income (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Turnover
148.0
126.5
Cost of Sales
57.2
41.9
Gross Profit
90.8
84.6
Operating Profit
-96.2
-44.5
Pre-Tax Profit
-102.2
-40.1
Profit / Loss for the Year
-85.7
-32.1
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.